To evaluate the in-vivo efficacy and safety of a hair care formulation in terms of reduction in Hair Fall and Anti-dandruff effect on healthy male & female subjects

Kama Ayurveda Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年4月4日

试验速览

暂无简介。

•1. Having moderate to severe hair fall.
•2. Having Moderate to severe dandruff (where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4
•3. Suffering with hair thinning on subject assessment basis.
•For female: Having at least shoulder length hair.
•Having washed their hair with provided neutral shampoo, 48 hours before the first day of the
•study with the provided nuetral shampoo.
•Having untangled their hair at home, 3 hours prior coming to the site for observations, the first
•day of the study.

•1. Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze).
•2. Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study.
•3. Having surgery history on the scalp (micro transplants â?¦)
•4. In the previous 6 months, Having undergone the Minoxidil treatments, Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide), Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids,Having modified her hormonal contraception.
•5. In the previous 3 months, Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc), Having taken a food supplement with an anti hair loss claim, Having taken an iron based treatment
•6. In the previous 15 days, Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim

发起方

Kama Ayurveda Pvt Ltd